{"cik":"0001719714","ticker":"MREO","name":"Mereo BioPharma Group plc","sic_code":"2834","sic_description":"Pharmaceutical Preparations","exchange":"Nasdaq","state_of_incorporation":"X0","fiscal_year_end":"1231","first_filing_date":"2026-05-12","last_filing_date":"2026-08-11","url":"/sec/cik-0001719714","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001193125-26-343519","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-11","title":"8-K — Mereo BioPharma Group plc — 2026-08-11","url_slug":"/sec/cik-0001719714/8-k/0001193125-26-343519","edgar_url":"https://www.sec.gov/Archives/edgar/data/1719714/0001193125-26-343519-index.html"},{"accession_number":"0001193125-26-343482","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-11","title":"8-K — Mereo BioPharma Group plc — 2026-08-11","url_slug":"/sec/cik-0001719714/8-k/0001193125-26-343482","edgar_url":"https://www.sec.gov/Archives/edgar/data/1719714/0001193125-26-343482-index.html"},{"accession_number":"0001193125-26-343533","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-11","title":"10-Q — Mereo BioPharma Group plc — 2026-08-11","url_slug":"/sec/cik-0001719714/10-q/0001193125-26-343533","edgar_url":"https://www.sec.gov/Archives/edgar/data/1719714/0001193125-26-343533-index.html"},{"accession_number":"0000070858-26-000293","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-05-14","title":"SCHEDULE 13G — Mereo BioPharma Group plc — 2026-05-14","url_slug":"/sec/cik-0001719714/schedule-13g/0000070858-26-000293","edgar_url":"https://www.sec.gov/Archives/edgar/data/1719714/0000070858-26-000293-index.html"},{"accession_number":"0001193125-26-223071","form_type":"8-K","form_type_family":"current","doc_date":"2026-05-14","title":"8-K — Mereo BioPharma Group plc — 2026-05-14","url_slug":"/sec/cik-0001719714/8-k/0001193125-26-223071","edgar_url":"https://www.sec.gov/Archives/edgar/data/1719714/0001193125-26-223071-index.html"},{"accession_number":"0001193125-26-218192","form_type":"8-K","form_type_family":"current","doc_date":"2026-05-12","title":"8-K — Mereo BioPharma Group plc — 2026-05-12","url_slug":"/sec/cik-0001719714/8-k/0001193125-26-218192","edgar_url":"https://www.sec.gov/Archives/edgar/data/1719714/0001193125-26-218192-index.html"},{"accession_number":"0001193125-26-218290","form_type":"8-K/A","form_type_family":"current","doc_date":"2026-05-12","title":"8-K/A — Mereo BioPharma Group plc — 2026-05-12","url_slug":"/sec/cik-0001719714/8-k-a/0001193125-26-218290","edgar_url":"https://www.sec.gov/Archives/edgar/data/1719714/0001193125-26-218290-index.html"},{"accession_number":"0001193125-26-218232","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-05-12","title":"10-Q — Mereo BioPharma Group plc — 2026-05-12","url_slug":"/sec/cik-0001719714/10-q/0001193125-26-218232","edgar_url":"https://www.sec.gov/Archives/edgar/data/1719714/0001193125-26-218232-index.html"}],"related_endpoints":{"profile":"/sec/MREO/profile","timeline":"/sec/MREO/timeline","peers":"/sec/MREO/peers","insider_pulse":"/sec/MREO/insider-pulse","insider_summary":"/sec/MREO/insider-summary","insider_transactions":"/sec/MREO/insider-transactions","form144":"/sec/MREO/form144","holdings_as_filer":"/sec/MREO/holdings","financial_facts":"/sec/MREO/financial-facts","derivatives":"/sec/MREO/derivatives","officers":"/sec/MREO/officers","insider_network":"/sec/MREO/insider-network","risk_flags":"/sec/MREO/risk-flags","filings":"/sec/MREO/filings","cross_topic_dossier":"/api/v1/dossier?ticker=MREO"}}